AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 25162916
Drug: Infusion prepared
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Infusion prepared from 2, 4, or 8 g of C. citratus leaves once daily for 30 days
Trial: 29934395
Drug: Morphine (M)
RxNorm normalized name: morphine Extended Release Oral Capsule [M-Eslon]
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine (M)
Trial: 26160958
Drug: Extended-release nicotinic
RxNorm normalized name: nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Extended-release nicotinic acid
Trial: 17966618
Drug: H2 blocker
RxNorm normalized name: capsaicin
DrugBank: Capsaicin (DB06774)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: H2 blocker (famotidine 20 mg)
Trial: 27358210
Drug: Brodalumab 140
RxNorm normalized name: brodalumab 140 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brodalumab 140 mg
Trial: 15679722
Drug: Loteprednol etabonate
RxNorm normalized name: Loteprednol Etabonate
DrugBank: Loteprednol etabonate (DB14596)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Loteprednol etabonate 100 microg nasal spray
Trial: 16260972
Drug: Oral carbohydrate
RxNorm normalized name: omega-3 carboxylic acids Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral carbohydrate (CHO) load (carbohydrate‐rich meal) during exercise
Trial: 12113564
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg i.v. droperidol over 5 minutes
Trial: 27716324
Drug: Sarilumab 200
RxNorm normalized name: SARILUMAB 200MG/1.14ML INJ SYR 1.14ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sarilumab 200 mg every 2 weeks (q2w)
Trial: 26656336
Drug: Artificial infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Artificial infusion solutions in the HAS group
Trial: 3528612
Drug: Captopril or
RxNorm normalized name: captopril Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Captopril or prazosin treatment in Group I patients
Trial: 9349064
Drug: Nebulised lignocaine
RxNorm normalized name: lidocaine hydrochloride Injectable Solution [Sure-Amp Lignocaine hydrochloride]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulised lignocaine (4 ml 4% lignocaine)
Trial: 10547251
Drug: Both interventions
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both interventions (Amoxicillin/clavulanate and Azithromycin)
Trial: 22986318
Drug: Intravenous (IV)
RxNorm normalized name: intravenous (IV) infusion pump
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (IV) lidocaine 1.5 mg/kg 20 minutes before incision followed by a continuous lidocaine infusion of 1.5 mg/kg/hr until the end of surgery
Trial: 25557316
Drug: Vitamin D
RxNorm normalized name: Vitamin D
DrugBank: Vitamin D (DB11094)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin D (1200 IU daily)
Trial: 29314350
Drug: Non-cancer treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-cancer treatment group (4-week online program)
Trial: 10954953
Drug: Sumatriptan nasal
RxNorm normalized name: SUMAtriptan nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan nasal spray (20 mg)
Trial: 10954953
Drug: Dihydroergotamine nasal
RxNorm normalized name: dihydroergotamine nasal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dihydroergotamine nasal spray (1 mg plus optional 1 mg)
Trial: 18626271
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (1.6 mg/kg) MDMA
Trial: 3614616
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of both steroids
Trial: 9543117
Drug: Calcium supplement
RxNorm normalized name: Calcium supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium supplement (714 mg Ca/day)
Trial: 17615800
Drug: Subcutaneous dalteparin
RxNorm normalized name: dalteparin
DrugBank: Dalteparin (DB06779)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous dalteparin (5000 IU) once daily
Trial: 15543329
Drug: Vitamin K(1)-containing
RxNorm normalized name: vitamin K 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin K(1)-containing multivitamin (25 mcg daily for 4 weeks)
Trial: 11994558
Drug: Combination drug
RxNorm normalized name: combination drugs used in erectile dysfunction
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination drug therapy with glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytics
Trial: 9685777
Drug: Prophylactic antibiotics
RxNorm normalized name: polylactic acid-polyglycolic acid copolymer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prophylactic antibiotics during intracranial pressure monitoring
Trial: 7863722
Drug: Chewable pyrantel
RxNorm normalized name: pyrantel Chewable Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chewable pyrantel pamoate tablets (swallow whole)
Trial: 24129363
Drug: 100 g-organic naked
RxNorm normalized name: castor oil
DrugBank: Castor oil (DB11113)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 g-organic naked oat with whole germ group (ONOG)
Trial: 24129363
Drug: 50 g-organic naked
RxNorm normalized name: castor oil
DrugBank: Castor oil (DB11113)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 g-organic naked oat with whole germ group (ONOG)
Trial: 20147968
Drug: 150 ml
RxNorm normalized name: REBYOTA 150 ML Enema
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 ml of fermented milk (FM)
Trial: 20147968
Drug: 300 ml
RxNorm normalized name: HYQVIA 30 GM / 300 ML Kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 ml of fermented milk (FM)
Trial: 31362034
Drug: Bi-anodal tDCS
RxNorm normalized name: bis-ethoxydiglycol succinate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bi-anodal tDCS (2 mA, twice-daily sessions for five consecutive days)
Trial: 28913630
Drug: Oral Appliance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral Appliance Therapy (OAT)
Trial: 17584705
Drug: Nitroglycerine sublingual
RxNorm normalized name: nitroglycerin Sublingual Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerine sublingual application
Trial: 31203197
Drug: Pseudomonas aeruginosa
RxNorm normalized name: Pseudomonas aeruginosa
DrugBank: Pseudomonas aeruginosa (DB19284)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudomonas aeruginosa eradication therapy
Trial: 31162787
Drug: Tapentadol sustained-release
RxNorm normalized name: tapentadol Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tapentadol sustained-release
Trial: 17163096
Drug: Adjuvant therapies
RxNorm normalized name: Theraplex Eczema Therapy
DrugBank: Colloidal oatmeal (DB11286)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant therapies including anthracycline- and taxane-based polychemotherapeutics, trastuzumab, with or without endocrine manipulation and with or without PMRT
Trial: 1875221
Drug: NABM infusion
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NABM infusion after CVP
Trial: 25557395
Drug: Ongoing outpatient
RxNorm normalized name: Ongo-Fin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ongoing outpatient therapy
Trial: 11894705
Drug: Intensive physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensive physical therapy (3.6 hours/week)
Trial: 314777
Drug: High-dosage ampicillin
RxNorm normalized name: hepatitis B surface antigen vaccine
DrugBank: Hepatitis B Vaccine (Recombinant) (DB11627)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dosage ampicillin (400 mg/kg per day)
Trial: 31888701
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of male-focused mobilization, community-based mobile HIV testing services, and a small incentive.
Trial: 7489472
Drug: Morphine 50
RxNorm normalized name: MORPHINE 50MG/NALTREXONE 2MG SA CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine 50 or 100 micrograms.kg‐1
Trial: 12365881
Drug: Compensated Work
RxNorm normalized name: dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Compensated Work Therapy (CWT)
Trial: 7752752
Drug: MMF 2
RxNorm normalized name: MMF
DrugBank: Monomethyl fumarate (DB14219)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMF 2 g
Trial: 12010356
Drug: Ritonavir (RTV)
RxNorm normalized name: Ritonavir
DrugBank: Ritonavir (DB00503)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ritonavir (RTV) 100-400 mg
Trial: 10543411
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg glimepiride
Trial: 17062365
Drug: FGF 2
RxNorm normalized name: FGF 2
DrugBank: Basic Fibroblast Growth Factor (DB14131)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FGF 2 L/min with 2% isoflurane
Trial: 1390326
Drug: Nitrendipine 20
RxNorm normalized name: nitrendipine 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrendipine 20 mg once a day
Trial: 23106926
Drug: Days of
RxNorm normalized name: Chapstick 12 Days of Christmas KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Days of maternal study medication received
Trial: 31140940
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg of orally administered alpha lipoic acid (ALA) once a day during the 12‐week period
Trial: 28575536
Drug: Infliximab treatment
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab treatment
Trial: 12432337
Drug: Medroxyprogesterone acetate
RxNorm normalized name: Medroxyprogesterone Acetate
DrugBank: Medroxyprogesterone acetate (DB00603)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Medroxyprogesterone acetate (MPA) 10 mg p.o. 12 days/month
Trial: 12432337
Drug: Transdermic nor-ethisterone
RxNorm normalized name: ethisterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermic nor-ethisterone acetate (NETA) 0.25 mg integrated in the ethinil-estradiol patches for the last two weeks of each cycle
Trial: 10628599
Drug: Conventional ventilation
RxNorm normalized name: VENTILATOR FILTER,THERMOFLO #6000S
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional ventilation (peak inflation pressure ≤50 cm H2O, tidal volume 10-15 mL/kg)
Trial: 16305563
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate 80 mg/1.5 mL gel solution
Trial: 19114685
Drug: Panitumumab added
RxNorm normalized name: Panitumumab
DrugBank: Panitumumab (DB01269)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Panitumumab added to bevacizumab and chemotherapy (oxaliplatin-based)
Trial: 3291523
Drug: Insulin injection
RxNorm normalized name: diluent for insulin lispro and regular insulin INJECTION VIAL (ML)
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin injection therapy
Trial: 12458394
Drug: Insulin-stimulated myocardial
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin-stimulated myocardial glucose uptake measured during hyperinsulinaemic euglycaemic glucose clamp with fluorine‐18 fluorodeoxyglucose.
Trial: 8427429
Drug: 0.5 mg
RxNorm normalized name: biotin 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.5 mg nalmefene IV
Trial: 29172732
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Irbesartan + Trichlormethiazide/Amlodipine/Efonidipine)
Trial: 22954563
Drug: High-concentration sodium
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: High-concentration sodium bicarbonate (833 mEq/L, n = 87)
Trial: 22954563
Drug: Low-concentration sodium
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-concentration sodium bicarbonate (160 mEq/L, n = 36)
Trial: 8889259
Drug: Sodium cromoglycate
RxNorm normalized name: Sodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium cromoglycate (dry powder 20 mg per inhalation and aqueous nasal spray 5.2 mg per dose)
Trial: 27042750
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human GH (rhGH) treatment with 25(OH)D above the 50th percentile
Trial: 22454414
Drug: Docetaxel 75
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 75 mg/m² IV over 1 hour for 21 days plus prednisone 5 mg orally twice per day plus bevacizumab 15 mg/kg IV every 3 weeks (DP + B)
Trial: 16913498
Drug: Western medicine
RxNorm normalized name: Medicaine Sting
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Western medicine
Trial: 25336114
Drug: Infliximab concentrations
RxNorm normalized name: Infliximab
DrugBank: Infliximab (DB00065)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Infliximab concentrations > 2.79 μg/mL
Trial: 9545673
Drug: Cefopzopran (CZOP)
RxNorm normalized name: cefozopran
DrugBank: Cefozopran (DB13667)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefopzopran (CZOP) 20.0 mg/kg
Trial: 9545673
Drug: Cefopzopran (CZOP)
RxNorm normalized name: cefozopran
DrugBank: Cefozopran (DB13667)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefopzopran (CZOP) 25.0 mg/kg
Trial: 22851554
Drug: Gemtuzumab ozogamicin
RxNorm normalized name: Gemtuzumab Ozogamicin
DrugBank: Gemtuzumab ozogamicin (DB00056)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Gemtuzumab ozogamicin (GO) 3 mg/m² on day 1 of course one of therapy
Trial: 12624625
Drug: Sodium nitroprusside
RxNorm normalized name: Sodium Nitroprusside
DrugBank: Nitroprusside (DB00325)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sodium nitroprusside (2‐8 micro g/min)
Trial: 3581030
Drug: CHOP with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHOP with intermediate dose methotrexate
Trial: 16287344
Drug: 18 g
RxNorm normalized name: flotufolastat F 18 gallium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 18 g dextrose as placebo (PL)
Trial: 11951158
Drug: High-intensity training
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity training program on cycle ergometers (5 training units weekly at 40 minutes each for a minimum of 22 training units during 4 weeks)
Trial: 24912456
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (TAU) for BD
Trial: 12776949
Drug: Low-dosage Group
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dosage Group (1.5 mg/kg of heparin)
Trial: 30175648
Drug: Cognitive-behavioral therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral therapy (CBT), 8 weekly sessions of 45-60 minutes each.
Trial: 16505497
Drug: Pioglitazone 45
RxNorm normalized name: pioglitazone 45 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone 45 mg
Trial: 9824184
Drug: Magnesium sulfate
RxNorm normalized name: Magnesium Sulfate
DrugBank: Magnesium (DB14513)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Magnesium sulfate (initial 6 g intravenous bolus followed by continuous infusion therapy 2 to 6 g/hr)
Trial: 15820077
Drug: Intravenous chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous chemotherapy (VC) - intravenously injected with an equal dose of aqueous carboplatin.
Trial: 10689885
Drug: Contrast medium
RxNorm normalized name: Contrased
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contrast medium volume of 2.0 <, < or = 2.5 ml/kg
Trial: 19294387
Drug: CI-1033 450
RxNorm normalized name: CI 77266
DrugBank: Carbon black (DB11980)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CI-1033 450 mg/day x 14 days every 21 days (arm C)
Trial: 11502525
Drug: Clinafloxacin (CI‐960)
RxNorm normalized name: Finafloxacin
DrugBank: Clinafloxacin (DB14025)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clinafloxacin (CI‐960) administered intravenously and orally, dosage not specified, single and twice-daily doses.
Trial: 8896541
Drug: High-titer vaccine
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-titer vaccine
Trial: 8896541
Drug: Low-titer vaccine
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-titer vaccine
Trial: 21108824
Drug: Selective Serotonin
RxNorm normalized name: Selective serotonin (5HT1) agonists
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective Serotonin Reuptake Inhibitors
Trial: 22950716
Drug: Intensified physical
RxNorm normalized name: hypochlorite
DrugBank: Hypochlorite (DB11123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intensified physical activity counseling (5 sessions integrated into routine maternity visits, monthly group meetings)
Trial: 28803087
Drug: Fentanyl buccal
RxNorm normalized name: Fentanyl Buccal Film
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl buccal tablet (FBT)
Trial: 25677254
Drug: Combination (Comb)
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination (Comb)
Trial: 29915988
Drug: Preoperative carbohydrate
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preoperative carbohydrate beverage (400 mL evening before and 400 mL morning before surgery)
Trial: 24335445
Drug: AZD9773 low
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: AZD9773 low dose
Trial: 24335445
Drug: AZD9773 high
RxNorm normalized name: HIGH DENSITY POLYETHYLENE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZD9773 high dose
Trial: 15772571
Drug: EPT every
RxNorm normalized name: leuprolide
DrugBank: Leuprolide (DB00007)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EPT every other day (0.625 mg of conjugated equine estrogen and 2.5 mg of medroxyprogesterone acetate)
Trial: 23599045
Drug: GLP-1 (7-36
RxNorm normalized name: GLP-1 (7-36) amide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GLP-1 (7-36 amide) infusion
Trial: 9645593
Drug: Inhaled beclomethasone
RxNorm normalized name: beclomethasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled beclomethasone dipropionate (BDP), 400 microg twice a day
Trial: 28958502
Drug: Gefitinib 250
RxNorm normalized name: gefitinib 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gefitinib 250 mg/day
Trial: 25846055
Drug: Delayed-release 6-mercaptopurine
RxNorm normalized name: 6-Mercaptopurine
DrugBank: Mercaptopurine (DB01033)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Delayed-release 6-mercaptopurine (DR-6MP)
Trial: 31172717
Drug: Oral methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methylprednisolone
Trial: 476709
Drug: Previous chemotherapy
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Previous chemotherapy with nitrosourea
Trial: 29903026
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (traditional medication)
Trial: 7021070
Drug: 4.0 g
RxNorm normalized name: Menthol 4.0 g in 100 mL TOPICAL GEL [BIOCOOL ROLL TYPE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4.0 g enteric-coated aspirin daily
Trial: 30855743
Drug: methyl aminolevulinate
RxNorm normalized name: Methyl aminolevulinate
DrugBank: Methyl aminolevulinate (DB00992)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: methyl aminolevulinate photodynamic therapy (MAL‐PDT)
Trial: 2060150
Drug: Pyridostigmine 60
RxNorm normalized name: pyRIDostigmine 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pyridostigmine 60 mg
Trial: 9825502
Drug: Antibodies to
RxNorm normalized name: Wong To Yick
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibodies to bacterial antigens (Reglicolipid, Streptococcus agalactiae polysaccharide, Staphylococcus aureus teichoic acid)
Trial: 23765409
Drug: Having negative
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Having negative views on generic medicines
Trial: 6139671
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate (100 mg three times a day)
Trial: 23538523
Drug: MMR+V coadministered
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MMR+V coadministered with DTaP‐IPV‐Hep B‐PRP‐T vaccine
Trial: 6307964
Drug: IV dose
RxNorm normalized name: Metered Dose Inhaler
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV dose of 441 mg ampicillin and 294 mg sulbactam
Trial: 9045106
Drug: Inactivated Lactobacillus
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated Lactobacillus acidophilus LB with rehydratant treatment for acute enteritis
Trial: 2222986
Drug: 40 mg/day
RxNorm normalized name: cabozantinib s-malate 140 mg/day (80 mg x 1-20 mg x 3/day) ORAL CAPSULE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg/day of baclofen